VYOME HOLDINGS, INC. Stock-Based Compensation
VYOME HOLDINGS, INC. (HIND) reported Stock-Based Compensation of $16.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $11.05K, a 7.91% decline year-over-year.
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $5.70K, a 62.03% decline year-over-year.
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.02K, a 79.87% decline year-over-year.
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $547.11K, a 1609.72% increase year-over-year.
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $577.13K, a 213.66% increase from fiscal 2024.
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $184.00K, a 75.98% decline from fiscal 2023.
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $766.00K, a 63.30% decline from fiscal 2022.
- VYOME HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.09M, a 82.93% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $16.75K 10-Q · filed 2026-08-12 | $19.77K derived: sum of 3 quarters · filed 2026-08-12 | $566.88K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $5.70K 10-Q · filed 2026-05-12 | $8.71K derived: sum of 2 quarters · filed 2026-05-12 | $555.82K derived: sum of 3 quarters · filed 2026-05-12 | $567.82K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2025-12-31 | $3.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $550.13K derived: sum of 2 quarters · filed 2026-03-18 | $562.13K derived: sum of 3 quarters · filed 2026-03-18 | $577.13K 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $547.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $559.11K derived: sum of 2 quarters · filed 2025-11-14 | $574.11K 10-Q · filed 2025-11-14 | $589.11K derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2025-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $27.00K 10-Q · filed 2025-08-14 | $42.00K derived: sum of 3 quarters · filed 2025-08-14 | $74.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2025-03-31 | $15.00K 10-Q · filed 2025-05-20 | $30.00K derived: sum of 2 quarters · filed 2025-05-20 | $62.00K derived: sum of 3 quarters · filed 2025-05-20 | $127.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $47.00K derived: sum of 2 quarters · filed 2025-04-04 | $112.00K derived: sum of 3 quarters · filed 2025-08-14 | $184.00K 10-K · filed 2025-04-04 | ||||
| 2024-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $97.00K derived: sum of 2 quarters · filed 2025-08-14 | $169.00K 10-Q · filed 2024-11-14 | $279.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $137.00K 10-Q · filed 2025-08-14 | $247.00K derived: sum of 3 quarters · filed 2025-08-14 | $463.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $72.00K 10-Q · filed 2025-05-20 | $182.00K derived: sum of 2 quarters · filed 2025-05-20 | $398.00K derived: sum of 3 quarters · filed 2025-05-20 | $616.00K derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $326.00K derived: sum of 2 quarters · filed 2025-04-04 | $544.00K derived: sum of 3 quarters · filed 2025-04-04 | $766.00K 10-K · filed 2025-04-04 | ||||
| 2023-09-30 | $216.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $434.00K derived: sum of 2 quarters · filed 2024-11-14 | $656.00K 10-Q · filed 2024-11-14 | $896.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $440.00K 10-Q · filed 2024-08-14 | $680.00K derived: sum of 3 quarters · filed 2024-08-14 | $1.04M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $222.00K 10-Q · filed 2024-05-15 | $462.00K derived: sum of 2 quarters · filed 2024-05-15 | $820.00K derived: sum of 3 quarters · filed 2024-05-15 | $2.31M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $598.00K derived: sum of 2 quarters · filed 2024-04-01 | $2.09M derived: sum of 3 quarters · filed 2024-04-01 | $2.09M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.85M derived: sum of 2 quarters · filed 2023-11-09 | $1.85M 10-Q · filed 2023-11-09 | $1.96M 10-Q · filed 2022-11-14 | $4.82M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $1.49M 10-K · filed 2023-04-17 | $1.49M 10-Q · filed 2023-08-07 | $1.57M 10-Q · filed 2022-08-19 | $4.46M derived: sum of 3 quarters · filed 2023-05-15 | $14.70M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2022-03-31 | $719.00K 10-Q · filed 2023-05-15 | $747.00K 10-Q · filed 2022-05-23 | $2.98M derived: sum of 2 quarters · filed 2023-05-15 | $13.21M derived: sum of 3 quarters · filed 2023-05-15 | $12.85M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $2.26M derived: 10-K 12 month − 10-K 9 month · filed 2023-04-17 | $12.49M derived: sum of 2 quarters · filed 2023-04-17 | $12.13M derived: sum of 3 quarters · filed 2023-04-17 | $12.23M 10-K · filed 2023-04-17 | $12.75M 10-K · filed 2022-04-08 | |||
| 2021-09-30 | $10.23M derived: 10-K 9 month − 10-Q 6 month · filed 2023-04-17 | $9.87M derived: sum of 2 quarters · filed 2023-04-17 | $9.97M 10-K · filed 2023-04-17 | $10.46M 10-Q · filed 2021-11-12 | $10.27M derived: sum of 4 quarters · filed 2023-04-17 | |||
| 2021-06-30 | -$364.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$263.00K 10-Q · filed 2022-08-19 | $31.00K derived: sum of 3 quarters · filed 2022-08-19 | $290.00K derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2021-03-31 | $101.00K 10-Q · filed 2022-05-23 | $91.00K 10-Q · filed 2021-05-12 | $395.00K derived: sum of 2 quarters · filed 2022-05-23 | $654.00K derived: sum of 3 quarters · filed 2022-05-23 | $946.00K derived: sum of 4 quarters · filed 2022-05-23 | |||
| 2020-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $553.00K derived: sum of 2 quarters · filed 2022-04-08 | $845.00K derived: sum of 3 quarters · filed 2022-04-08 | $1.32M 10-K · filed 2022-04-08 | $1.09M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $259.00K 10-Q · filed 2020-11-06 | $551.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.03M 10-Q · filed 2021-11-12 | $1.02M 10-Q · filed 2020-11-06 | $1.70M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-06-30 | $292.00K 10-Q · filed 2020-07-30 | $774.00K 10-Q · filed 2021-08-16 | $762.00K 10-Q · filed 2020-07-30 | $1.45M derived: sum of 3 quarters · filed 2021-05-12 | $2.10M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-03-31 | $470.00K 10-Q · filed 2021-05-12 | $1.15M derived: sum of 2 quarters · filed 2021-05-12 | $1.81M derived: sum of 3 quarters · filed 2021-05-12 | $2.35M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $683.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.34M derived: sum of 2 quarters · filed 2021-03-12 | $1.88M derived: sum of 3 quarters · filed 2021-03-12 | $2.98M 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | $659.00K 10-Q · filed 2020-11-06 | $1.20M derived: sum of 2 quarters · filed 2020-11-06 | $2.30M 10-Q · filed 2020-11-06 | $3.38M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $536.00K 10-Q · filed 2020-07-30 | $1.64M 10-Q · filed 2020-07-30 | $2.72M derived: sum of 3 quarters · filed 2020-07-30 | $3.73M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2019-03-31 | $1.10M 10-Q · filed 2020-06-19 | $2.19M derived: sum of 2 quarters · filed 2020-06-19 | $3.19M derived: sum of 3 quarters · filed 2020-06-19 | $4.41M derived: sum of 4 quarters · filed 2020-06-19 | ||||
| 2018-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $2.09M derived: sum of 2 quarters · filed 2020-02-27 | $3.31M derived: sum of 3 quarters · filed 2020-02-27 | $4.69M 10-K · filed 2020-02-27 | ||||
| 2018-09-30 | $1.01M 10-Q · filed 2019-11-08 | $2.22M derived: sum of 2 quarters · filed 2019-11-08 | $3.61M 10-Q · filed 2019-11-08 | $4.75M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $1.22M 10-Q · filed 2019-07-24 | $2.60M 10-Q · filed 2019-07-24 | $3.74M derived: sum of 3 quarters · filed 2019-07-24 | $4.77M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-03-31 | $1.39M 10-Q · filed 2019-05-10 | $2.53M derived: sum of 2 quarters · filed 2019-05-10 | $3.55M derived: sum of 3 quarters · filed 2019-05-10 | $4.17M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $2.16M derived: sum of 2 quarters · filed 2019-02-22 | $2.78M derived: sum of 3 quarters · filed 2019-02-22 | $3.24M 10-K · filed 2019-02-22 | ||||
| 2017-09-30 | $1.02M 10-Q · filed 2018-11-02 | $1.64M derived: sum of 2 quarters · filed 2018-11-02 | $2.10M 10-Q · filed 2018-11-02 | $2.46M derived: sum of 4 quarters · filed 2018-11-02 | ||||
| 2017-06-30 | $616.00K 10-Q · filed 2018-08-02 | $1.08M 10-Q · filed 2018-08-02 | $1.44M derived: sum of 3 quarters · filed 2018-08-02 | $1.50M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $463.00K 10-Q · filed 2018-05-10 | $826.00K derived: sum of 2 quarters · filed 2018-05-10 | $881.00K derived: sum of 3 quarters · filed 2018-05-10 | $976.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $418.00K derived: sum of 2 quarters · filed 2018-03-05 | $513.00K derived: sum of 3 quarters · filed 2018-03-05 | $563.00K 10-K · filed 2018-03-05 | ||||
| 2016-09-30 | $55.00K 10-Q · filed 2017-11-03 | $150.00K derived: sum of 2 quarters · filed 2017-11-03 | $200.00K 10-Q · filed 2017-11-03 | $254.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-06-30 | $95.00K 10-Q · filed 2017-08-02 | $145.00K 10-Q · filed 2017-08-02 | $199.00K derived: sum of 3 quarters · filed 2018-03-05 | $252.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-03-31 | $50.00K 10-Q · filed 2017-05-10 | $104.00K derived: sum of 2 quarters · filed 2018-03-05 | $157.00K derived: sum of 3 quarters · filed 2018-03-05 | |||||
| 2015-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $107.00K derived: sum of 2 quarters · filed 2018-03-05 | $207.00K 10-K · filed 2018-03-05 | |||||
| 2015-09-30 | $53.00K 10-Q · filed 2016-11-10 | $153.00K 10-Q · filed 2016-11-10 | ||||||
| 2014-12-31 | $185.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |